Abstract:
A method of isolating 99Mo produced using a (n,γ) reaction according to example embodiments may include vaporizing a source compound containing 98Mo and 99Mo. The vaporized source compound may be ionized to form ions containing 98Mo and 99Mo. The ions may be separated to isolate the ions containing 99Mo. The isolated ions containing 99Mo may be collected with a collector. Accordingly, the isolated 99Mo may have a relatively high specific radioactivity and, in turn, may be used to produce the diagnostic radioisotope, 99mTc, through radioactive decay.
Abstract:
A method of isolating 186Re according to example embodiments may include vaporizing a source compound containing 185Re and 186Re. The vaporized source compound may be ionized to form negatively-charged molecules containing 185Re and 186Re. The negatively-charged molecules may be separated to isolate the negatively-charged molecules containing 186Re. The isolated negatively-charged molecules containing 186Re may be collected with a positively-charged collector. Accordingly, the isolated 186Re may be used to produce therapeutic and/or diagnostic radiopharmaceuticals having higher specific activity.
Abstract:
A method of isolating 99Mo produced using a (n,γ) reaction according to example embodiments may include vaporizing a source compound containing 98Mo and 99Mo. The vaporized source compound may be ionized to form ions containing 98Mo and 99Mo. The ions may be separated to isolate the ions containing 99Mo. The isolated ions containing 99Mo may be collected with a collector. Accordingly, the isolated 99Mo may have a relatively high specific radioactivity and, in turn, may be used to produce the diagnostic radioisotope, 99mTc, through radioactive decay.
Abstract:
A method of isolating 186Re according to example embodiments may include vaporizing a source compound containing 185Re and 186Re. The vaporized source compound may be ionized to form negatively-charged molecules containing 185Re and 186Re. The negatively-charged molecules may be separated to isolate the negatively-charged molecules containing 186Re. The isolated negatively-charged molecules containing 186Re may be collected with a positively-charged collector. Accordingly, the isolated 186Re may be used to produce therapeutic and/or diagnostic radiopharmaceuticals having higher specific activity.
Abstract translation:根据示例性实施方案的分离 u> Re的方法可以包括蒸发含有CH 2 Re和C 14 Re 12 Re的源化合物。 蒸发的源化合物可以被离子化以形成含有185 Re Re和Re Re 18 Re的带负电荷的分子。 可以分离带负电荷的分子以分离含有 ref> Re Re的带负电荷分子。 可以用带正电收集器收集分离的含有<! - SIPO - > Re的带负电荷分子。 因此,分离的186 Re可用于产生具有较高比活性的治疗和/或诊断性放射性药物。
Abstract:
A method of isolating a radioisotope according to example embodiments may include vaporizing a source compound containing a first isotope and a second isotope of an element, wherein the second isotope may have at least one of therapeutic and diagnostic properties when used as a radiopharmaceutical. The vaporized source compound may be ionized to form charged particles of the first and second isotopes. The charged particles may be separated to isolate the particles of the second isotope. The isolated charged particles of the second isotope may be collected with an oppositely-charged collector. Accordingly, the isolated second isotope may be used to produce therapeutic and/or diagnostic radiopharmaceuticals having higher specific activity.
Abstract:
A method of isolating a radioisotope according to example embodiments may include vaporizing a source compound containing a first isotope and a second isotope of an element, wherein the second isotope may have at least one of therapeutic and diagnostic properties when used as a radiopharmaceutical. The vaporized source compound may be ionized to form charged particles of the first and second isotopes. The charged particles may be separated to isolate the particles of the second isotope. The isolated charged particles of the second isotope may be collected with an oppositely-charged collector. Accordingly, the isolated second isotope may be used to produce therapeutic and/or diagnostic radiopharmaceuticals having higher specific activity.
Abstract:
Disclosed are methods for determining the energy of a particle beam, for example a proton beam, by measuring the ratio of the radioactivities associated with two radioisotopes that are simultaneously produced within a plurality of target foils versus the calculated beam energy drop through each individual foil. This method relies on the disparate production of related radioisotopes in a single material as a function of the beam energy. A calibration curve may be established by irradiating target metal foils of known thickness and measuring the relative radioactivities of at least two target radioisotopes resulting from that irradiation. In particular, the method can be used to determine beam energies in the 10 to 18 MeV range by measuring the relative production of 63Zn and 65Zn in natural Cu foils.